In a study utilizing a human colon cancer model (HTC‐116), the efficacy of the cetuximab therapy response was demonstrated through the NIR fluorescence of vascular endothelial growth factor (VEGF) expression. This evidence concerns the gene VEGFA and malignant colon neoplasm.